baber/WOPTO huggingface dataset:
Patent ES-557235-A0 (ES)
IPC: C07D471/04
Filed: 1986-12-01
Abstract: 5-(6-Imidazo[1,2-a]pyridyl)pyridine derivatives represented by general formula: wherein X represents hydrogen atom or methyl group; Y represents cyano group, carboxamido group, hydrogen atom, amino group or a halogen atom; Z represents hydrogen atom or a lower alkyl group; W represents hydrogen atom or a lower alkyl group; R' represents hydrogen atom, a lower alkyl group, phenyl group, a group shown by formula: -CH<sub>2</sub>R<sup>4</sup> in which R<sup>4</sup> is a lower alkoxy group, or a group shown by formula:in which R<sup>5</sup> and R<sup>6</sup> are hydrogen atom or a lower alkyl group; R<sup>2</sup> represents hydrogen atom or a halogen atom; and R<sup>3</sup> represents hydrogen atom, a lower alkyl group or a halogen atom; or a tautomer thereof; and pharmacologically acceptable salts thereof are disclosed. The 5-(6-imidazo[1,2-a]-pyridyl) pyridine derivatives are effective for treating congestive heart failures.
Patent FI-840027-A0 (FI)
Inventor: HENNING RAINER
IPC: C07D209/52
Filed: 1984-01-05
Abstract: The invention relates to compounds of the formula    <IMAGE>  (I)  in which R1 and R2 are identical or different and represent alkyl or aryl or together form a C chain and R3 denotes alkyl or aryl, a process for their preparation and their use.
Patent FI-861262-A0 (FI)
Inventor: YAMANAKA MOTOSUKE
IPC: C07D471/04
Filed: 1986-03-25
Abstract: 5-(6-Imidazo[1,2-a]pyridyl)pyridine derivatives represented by general formula: wherein X represents hydrogen atom or methyl group; Y represents cyano group, carboxamido group, hydrogen atom, amino group or a halogen atom; Z represents hydrogen atom or a lower alkyl group; W represents hydrogen atom or a lower alkyl group; R' represents hydrogen atom, a lower alkyl group, phenyl group, a group shown by formula: -CH<sub>2</sub>R<sup>4</sup> in which R<sup>4</sup> is a lower alkoxy group, or a group shown by formula:in which R<sup>5</sup> and R<sup>6</sup> are hydrogen atom or a lower alkyl group; R<sup>2</sup> represents hydrogen atom or a halogen atom; and R<sup>3</sup> represents hydrogen atom, a lower alkyl group or a halogen atom; or a tautomer thereof; and pharmacologically acceptable salts thereof are disclosed. The 5-(6-imidazo[1,2-a]-pyridyl) pyridine derivatives are effective for treating congestive heart failures.
Patent FI-874218-A0 (FI)
Inventor: HAMPL JR VLADIMIR
IPC: D21H21/34
Filed: 1987-09-25
Abstract: Wrappers (10) for smoking articles (18) providing reduced ignition proclivity or self-extinguishing properties to the resultant smoking articles (18). The wrapper materials (10) contain band areas of low inherent BMI in the range from about 0 to about 4 cm<-><1>. Preferred embodiments include wrappers (10) wherein bands (14) of paper material with reduced filler content are provided to produce a BMI in the range of from about 0 to about 2 cm<-><1> in the band areas and the resulting smoking articles (18) are self-extinguishing in the banded zones (24). The width of the bands (14) may be in the range of from about 2 to about 20 millimeters and, for self-extinguishing properties, are preferably at least about 6 millimeters.
Patent FI-882072-A0 (FI)
Inventor: SCHIRLIN DANIEL
IPC: C07F7/08
Filed: 1988-05-04
Abstract: This invention relates to substituted silyl alkylene amines, to the intermediates and processes useful for their preparation, to their pharmacological use as MAO-B inhibitors and to their end-use application in the treatment of Parkinson's Disease.
Patent FI-895740-A0 (FI)
Inventor: MAKRIS PERRY
IPC: H04L12/56
Filed: 1989-11-30
Abstract: A packet switch receives data and processes it for assembly into packages. A bus allows communication between each of the data processing units of the switch and one or more storage units for storing the data packets. Arbitration for deciding which of the processing units will be granted access to the bus is performed by a system which selectively and alterably designates any of at least two different levels of priority of access to the bus for each of the processing units, and the relative percentages of time of access for the different priorty levels. The system assures greater access to the bus by those of the processing units having the higher level of priority. If communication is provided by two buses, the requests for access are alternated between them. The arbitration system provides selective access to the bus in any of a plurality of bus cycles including a read cycle, a write cycle and a read/modify/write cycle, and grants a request for access from a higher priority processing unit within one bus cycle.
Patent FI-896054-A0 (FI)
Inventor: SJOESTROEM HAOKAN
IPC: C08F10/14
Filed: 1989-12-18
Abstract: The invention concerns a polyethyleneacrylate co- or ter-polymer that can be cross-linked. It contains unsaturated acrylate bonds, because of which the polymer can be cross-linked efficiently by means of ionizing radiation or chemically by means of peroxides.
Patent FI-900280-A0 (FI)
Inventor: ZAHN KLAUS
IPC: F16H61/70
Filed: 1990-01-17
Abstract: A gear box, particularly with power shift stage, connected downstream of an internal combustion engine is shifted between at least two speed transmission ratios according to the internal combustion engine load. In order to improve the ride comfort and to increase productivity, an automatic operating device is proposed for this purpose. This contains a switch appliance (33) connected to an adjusting element (40) for the fuel supply, a device (34) for registering the speed of the combustion engine and a control unit (36). The signals from the switch appliance (33) and the speed registering device (34) are fed to the control unit (36). The control unit (36) analyses these signals and, if a presettable fuel feed adjustment value and at least one presettable engine speed value are either exceeded or not reached, emits control signals for automatic shifting to the gear box (10). The control unit (36) is preferably activated when the fuel feed adjustment value corresponds to the full throttle value. 
<IMAGE>
Patent FI-910378-A0 (FI)
Inventor: ZIBELL STEVEN E
IPC: A23L27/30
Filed: 1991-01-25
Abstract: A process is disclosed for making a chewing gum with a fast release, stabilized chewing gum. According to the method, a quantity of aspartame (APM) is mixed with an agglomerating agent, such as a modified cellulose, and a limited quantity of a solvent for the agglomerating agent, such as water. The quantity of solvent is limited so as to produce a mixture which is only moist or damp. This damp mixture is characterized as being dust-free, non-flowing and crumbly. The damp mixture is then dried and the dried mixture is comminuted, e.g. by grinding, to produce particles of APM ingredient with essentially a maximum particle size of about 0.017 inches. These particles of APM ingredient are then added to a chewing gum formulation.
Patent FI-913412-A0 (FI)
Inventor: BOETTCHER JUERGEN
IPC: F28F3/04
Filed: 1991-07-15
Abstract: In the card of ceramic material for building up permeable structures, the card (1) has three rows of holes extending parallel to one another and arranged symmetrically in relation to the axes of symmetry. Three recesses (3, 4, 5) of differing length are arranged between the rows of holes. The recesses intersect the card edge (10,11), the longest (3) and one of the two shorter (4,5) opening out at the same card edge (10) and the shortest (5) being opposite the second longest (4). The webs (6, 6a) remaining between the recesses (4,5) and between the recess (3) and the card edge (11) have a length of 25% +/- 0 to 6% in relation to the length of the card 1 determined by the direction of the rows of holes. 
<IMAGE>
Patent FI-914376-A0 (FI)
Inventor: STRASSER JEAN PAUL
IPC: E04F19/02
Filed: 1991-09-18
Abstract: A foam profile for covering the junction region between wall and ceiling or wall and floor of a room is provided, which possesses at the rear a retaining profile (7, 8) into which the tongues (9, 10) of mountings (1) engage. The mountings 1 fixed in the wall-ceiling junction region thus carry the profile (2), the arrangement according to the invention of profile (2) and mountings (1) also being able to form the border of a suspended ceiling to the walls and at the same time assume supporting functions for the edge ceiling elements of the suspended ceiling. The suspended ceiling can be a coffered ceiling, the coffer frames of which are formed from the profiles (2). The corners, formed in each case by two profiles, of a coffer frame are held together by angle mountings or spring clasps. <IMAGE>
Patent FI-932759-A0 (FI)
Inventor: ROZHON EDWARD J
IPC: A61K38/00
Filed: 1993-06-16
Abstract: A use of IL-4 for the manufacture of a medicament, a pharmaceutical composition comprising IL-4 and a pharmaceutically acceptable carrier and a method for enhancing a primary immune response of a mammal to immunogens present in a vaccine, e.g., the tetanus toxoid vaccine in mammals by administering to such mammals an effective amount of IL-4, preferably recombinant human or E. coli-derived IL-4 in association with said vaccine are disclosed.
Patent FI-935822-A0 (FI)
Inventor: BIGNELL NOEL
IPC: G01P5/18
Filed: 1993-12-23
Abstract: PCT No. PCT/AU92/00314 Sec. 371 Date Mar. 15, 1994 Sec. 102(e) Date Mar. 15, 1994 PCT Filed Jun. 25, 1992 PCT Pub. No. WO93/00569 PCT Pub. Date Jan. 7, 1993An electronic fluid flowmeter includes an LSI digital device and an LSI analog device. The digital device drives a pair of acoustic transducers to transmit acoustic waves within a fluid, the flow of which is being measured. The acoustic waves are received within the analogue device, the moment of arrival being determined by envelope detection associated with the phase of the received signal. The reception of a signal stops a counter within the digital device, the value in the counter representing the time of flight of the acoustic signals within the fluid. Fluid flow data can be stored on an EEPROM from which meter data can be read using a liquid crystal display or via an interface port to an external device.
Patent FI-944607-A0 (FI)
Inventor: RUSSELL TREVOR JOHN
IPC: C10L1/16
Filed: 1994-10-03
Abstract: PCT No. PCT/GB93/00698 Sec. 371 Date Nov. 29, 1994 Sec. 102(e) Date Nov. 29, 1994 PCT Filed Apr. 2, 1993 PCT Pub. No. WO93/20170 PCT Pub. Date Oct. 14, 1993.A multi-functional gasolene detergent composition providing good balance of properties leading to reduced engine deposits, little or no valve stick, and without effect on Octane Requirement Increase. The composition contains an polyisobutenyl succinimide detergent, a mono end-capped polypropylene glycol as the carrier oil and a hydrocarbon solvent.
Patent FI-950955-A0 (FI)
Inventor: DELIMOY DIDIER
IPC: C08K3/04
Filed: 1995-03-01
Abstract: Thermoplastic material comprises a thermoplastic polymer(s), a reinforcing fibrous material(s) and a material which absorbs IR rays and present at 1-1000 ppm. Also claimed is the prodn. of a thermoplastic article by IR irradiating the above material.
Patent FI-954233-A0 (FI)
Inventor: TROMBACH HORST
IPC: B65D53/04
Filed: 1995-09-08
Abstract: PCT No. PCT/EP94/00777 Sec. 371 Date Sep. 8, 1995 Sec. 102(e) Date Sep. 8, 1995 PCT Filed Mar. 14, 1994 PCT Pub. No. WO94/21524 PCT Pub. Date Sep. 29, 1994A sealing cover for an opening of a container has a first foil that seals the opening of the container. A metallic foil, especially aluminum foil, is also provided for inductive sealing of the first foil at the lip of the opening, along with a removable sealing lid that is releasably screwed onto the container. A releasable adhesive control layer positioned between the first foil and the metallic foil, enables the metallic foil to be detached from the first foil after the sealing lid has been removed. An elastic layer is provided between the sealing lid and the metallic foil. Between the metallic foil and the elastic layer is a separation layer, which becomes liquid at induction temperatures, and a suction layer. During the induction process, the latter absorbs the liquified substance of the separation layer. The adhesive control layer does not have such an adjoining suction layer.
Patent FI-961407-A0 (FI)
Inventor: MURPHY TIMOTHY F
IPC: A61K39/00
Filed: 1996-03-28
Abstract: Compositions comprising outer membrane protein "CD", and peptides and oligopeptides thereof, of Branhamella catarrhalis are described. Additionally, nucleotide sequences encoding the protein, peptide or oligopeptide are disclosed, as well as recombinant vectors containing these sequences. Protein, peptide or oligopeptide can be produced from host cell systems containing these recombinant vectors. Peptides and oligopeptides can also be chemically synthesized. Disclosed are the uses of the protein, peptides and oligopeptides as antigens for vaccine formulations, and as antigens in diagnostic immunoassays. The nucleotide sequences are useful for constructing vectors for use as vaccines for insertion into attenuated bacteria in constructing a recombinant bacterial vaccine, and for inserting into a viral vector in constructing a recombinant viral vaccine. Also described is the use of nucleotide sequences related to the gene encoding CD as primers and/or probes in molecular diagnostic assays for the detection of B. catarrhalis.
Patent IL-63628-A0 (IL)
Title: Dna transfer vectors for bovine pre-growth and growth hormones and processes for the preparation thereof
IPC: C12P21/02
Filed: 1981-08-20
Abstract: A DNA transfer vector comprises a deoxynucleotide sequence coding for bovine growth hormone or bovine pre-growth hormone.
Patent IL-74645-A0 (IL)
Title: Furan,thiophene and pyrrole derivatives and their preparation
IPC: G01N33/50
Filed: 1985-03-19
Abstract: A novel compound useful in detecting leukocytes, esterase and protease in a test sample. The compound has the structurein which: A is an acid residue, R is lower alkyl, aryl, carboxyl, carboxyl ester, amido or cyano, R<sup>*</sup> is H or lower alkyl, and X is 0, S, or NR', in which R' is H, lower alkyl or aryl.
Patent IL-79337-A0 (IL)
Title: Esters and amides of eicosatriynoic acid,their preparation and cosmetic and pharmaceutical compositions containing them
IPC: A61K31/202
Filed: 1986-07-04
Abstract: Processes for preparing 5,8,11-eicosatriynoic acid as well as esters and amides thereof involves initially preparing the acid by reacting 1-decyne with 1,4-dihalo-2-butyne in the presence of a strong base to form 1-halo-2,5-tetradecadiyne which is then reacted with 5-hexynoic acid so as to form 5,8,11-eicosatriynoic acid. This acid can then be converted to the acid chloride form and reacted with an alcohol to form an ester or converted to a potassium salt and reacted with a halide also to form an ester, or after conversion to an acid chloride reacted with an amine in the presence of a tertiary amine to form an amide, or the acid can be reacted with carbonyldiimidazole in the presence of a solvent and excess amine to form an amide.
Patent IL-91413-A0 (IL)
Title: Process and solution for lyophilization of cells
IPC: A61K35/18
Filed: 1989-08-24
Abstract: A method and medium are disclosed for the reconstitution of lyophilized cells. The method comprises the step of contacting the cells with an aqueous solution containing a carbohydrate in a concentration of at least 0.7% by weight and/or a polymer having a molecular weight of from 1K to 360K in a concentration of up to 20% by weight.
Patent IL-91918-A0 (IL)
Title: Fluid drain system for wounds
IPC: A61M25/02
Filed: 1989-10-06
Abstract: A fluid drain for wounds includes a tube (2) having one end insertable under the patient's skin into the wound, with the opposite end of the tube extending externally of the patient's skin; and a valve assembly (18) at the opposite end of the tube (2). The valve assembly (18) includes a first port (31) for connection to a vacuum source, a second port (32) connected to the opposite end of the tube (2), a third port (33) for outletting the drained fluid into a container, a first one-way valve permitting the fluid to flow freely therethrough only from the second port (32) to the first port (31), and a second one-way valve permitting the fluid to flow freely therethrough only from the first port (31) to the third port (33). <IMAGE>
Patent IL-94382-A0 (IL)
Title: Piperidinyl,pyrrolidinyl and piperazinyl alkylphenol ethers,their preparation and antiviral compositions comprising them
IPC: A61K31/496
Filed: 1990-05-14
Abstract: Piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers of formula <CHEM> X is N or CH; Alk is C1-4alkanediyl; R<1> and R<2> are hydrogen, C1-4alkyl or halo; R<3> is hydrogen, halo, cyano, C1-4alkyloxy, aryl or -COOR<4>, with R<4> being hydrogen, C1-4alkyl, arylC1-4alkyl, C3-6cycloalkylC1-4alkyl, C3-5alkenyl, C3-5alkynyl or C1-4alkyloxyC1-4alkyl; or R<3> is a radicai of formula <CHEM> the addition salts and stereochemically isomeric forms thereof, said compounds having antirhinoviral activity. Pharmaceutical compositions containing these compounds as active ingredient, and a method of preparing said compounds and pharmaceutical compositions.
Patent IL-96810-A0 (IL)
Title: Supported ionic metallocene catalysts for olefin polymerization and methods for the preparation thereof
IPC: C08F4/6592
Filed: 1990-12-27
Abstract: A supported catalyst for olefin polymerization comprising a Group IV-B metallocene component and an ionic activator componenet comprising a cation capable of donating a proton and a labile bulky anion having a plurality of lipophilic radicals so that the anion is sterically hindered from covalently bonding with a cation produced from the Group IV-B metal of the metallocene.
Patent IL-102367-A0 (IL)
Title: Triazolopyrimidine derivatives which are angiotensin ii receptor antagonists;processes for preparing them and pharmaceutical compositions containing them
IPC: C07D239/47
Filed: 1992-06-30
Abstract: The present invention relates to the derivatives of formula: <IMAGE> Formula (I)  as well as to their addition salts and to their use in therapy, in particular for the treatment of cardiovascular diseases, especially for the treatment of hypertension, cardiac insufficiency and diseases of the arterial wall.
Patent IL-107758-A0 (IL)
Title: Catechol diethers as selective pde inhibitors
IPC: C07C205/44
Filed: 1993-11-25
Abstract: This invention relates to 4-substituted catechol diether compounds which are selective inhibitors of phosphodiesterase (PDE) type IV. The compounds of the present invention are useful in inhibiting PDEIV and in the treatment of AIDS, asthma, arthritis, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis and other inflammatory diseases. This invention also relates to pharmaceutical compositions comprising the compounds hereof.
Patent IL-116516-A0 (IL)
Title: Process for the purification of melamine
IPC: C07D251/62
Filed: 1995-12-22
Abstract: In a melamine purifying process, impure melamine is heated up to a temperature above 200  DEG C but below the ammonia pressure-dependent, momentary melting point of melamine, and is kept in a solid state in said temperature range under an ammonia pressure from 5 to 350 bars for a period from 1 minute to 20 hours. It is then expanded and cooled down to room temperature, in whatever order, to produce pure melamine in powder form.
Patent IL-126601-A0 (IL)
Title: Method and mechanism for closing the toe at the start of the process of making a stocking or sock in a circular knitting machine
IPC: D04B9/24
Filed: 1997-04-28
Abstract: PCT No. PCT/IT97/00097 Sec. 371 Date Oct. 21, 1998 Sec. 102(e) Date Oct. 21, 1998 PCT Filed Apr. 28, 1997 PCT Pub. No. WO97/41288 PCT Pub. Date Nov. 6, 1997The fabric (T) for the toe pouch is first formed by the needles (1) of a first semicircle (A), and then, in order to transfer the initial free edge (T1) of said pouch (T) to the needles of the complementary arc and thus to start the tubular fabric, a region of concentrated suction of air is created by of a mouth (22) extending around the inside of a portion of the needle circle in order to capture said free edge of the pouch in transit; next, by a centrifugal movement of sinkers each provided with a spike, said free edge (T1) is moved progressively out beyond the circle of the needles, which rise and pass through the fabric (T) around said initial edge (T1).
Patent IL-129466-A0 (IL)
Title: Method for detecting live microbiological contaminants in a food product sample
IPC: C12Q1/6895
Filed: 1997-10-27
Abstract: A process for detecting live microbiological contaminants in a food product sample, according to which the presence of mRNA coding for the synthesis of a protein involved in the synthesis of proteins by the contaminants is detected in the sample.
Patent IL-142313-A0 (IL)
Title: Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
IPC: C08G63/08
Filed: 1999-09-30
Abstract: A water soluble, biodegradable ABA- or BAB-type tri-block polymer is disclosed that is made up of a major amount of a hydrophobic A polymer block made of a biodegradable polyester and a minor amount of a hydrophilic polyethylene glycol(PEG) B polymer block, having an overall average molecular weight of between about 2000 and 4990, and that possesses reverse thermal gelation properties. Effective concentrations of the tri-block polymer and a drug may be uniformly contained in an aqueous phase to form a drug delivery composition. At temperatures below the gelation temperature of the tri-block polymer the composition is a liquid and at temperatures at or above the gelation temperature the composition is a gel or semi-solid. The composition may be administered to a warm-blooded animal as a liquid by parenteral, ocular, topical, inhalation, transdermal, vaginal, transurethral, rectal, nasal, oral, pulmonary or aural delivery means and is a gel at body temperature. The composition may also be administered as a gel. The drug is released at a controlled rate from the gel which biodegrades into non-toxic products. The release rate of the drug may be adjusted by changing various parameters such as hydrophobic/hydrophilic component content, polymer concentration, molecular weight and polydispersity of the tri-block polymer. Because the tri-block polymer is amphiphilic, it functions to increase the solubility and/or stability of drugs in the composition.
Patent IL-143872-A0 (IL)
Title: Method for preparing methyl carbazate
IPC: C07C281/02
Filed: 2000-01-17
Abstract: Methyl carbazate which is particularly pure and has a particularly low tendency toward discoloration is obtained from hydrazine and dimethyl carbonate if the two reactants are metered simultaneously into an initially introduced first solvent at from -20 to +30° C., the solvent and low-boiling components are then distilled off under reduced pressure, and then either a second solvent is added to the crude methyl carbazate present and this solvent is distilled off under reduced pressure or an inert gas is passed through the crude methyl carbazate present.
Patent IL-146132-A0 (IL)
Title: Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatments
IPC: A61P29/00
Filed: 2000-05-25
Abstract: Use of an anti-infective and/or anti-inflammatory agent for the preparation of a pharmaceutical composition for the treatment of diseases of external or internal parts of the human or animal body which are susceptible to the administration of such agents.
Patent IL-146228-A0 (IL)
Title: A method of screening compounds
IPC: A61K8/49
Filed: 2000-06-27
Abstract: Methods of screening for compounds that affect melanogenesis and the function of P protein in organisms, cells, or cell-free systems are provided. The invention further relates to the pharmacologic and cosmetic uses of such compounds to reduce or increase the synthesis of melanin in animal and human melanocytes and melanocyte-derived cells.